Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy

Although postoperative adjuvant chemotherapy (PAC) with uracil–tegafur significantly improves the prognosis of patients with stage I lung adenocarcinoma, subset analysis has revealed that only 11.5% of patients with stage IB derive actual benefit from such therapy. Therefore, it is extremely importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, J, Hirano, T, Ogiwara, A, Akimoto, S, Kawakami, T, Fukui, Y, Oka, T, Gong, Y, Guo, R, Inada, H, Nawa, K, Kojika, M, Suga, Y, Ohira, T, Mukai, K, Kato, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243141/
https://www.ncbi.nlm.nih.gov/pubmed/18212748
http://dx.doi.org/10.1038/sj.bjc.6604197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243141/
https://www.ncbi.nlm.nih.gov/pubmed/18212748
http://dx.doi.org/10.1038/sj.bjc.6604197

Ejemplares similares